The Limited Times

Now you can see non-English news...

Following the corona: Shufersal revenue record in 2020 | Israel today

2021-03-03T20:28:22.028Z

| economy The chain, which grew by 16% in the last quarter of the year, makes one-fifth of retail sales • Net profit: more than NIS 380 million • And also: How much did online sales increase? Shufersal. Broke records Photo:  Eyal Margolin, Ginny Shufersal recorded a record revenue in 2020, which generated more than NIS 15.2 billion. The company's net profit amounted to NIS 387 million, about 2.5% of re



The chain, which grew by 16% in the last quarter of the year, makes one-fifth of retail sales • Net profit: more than NIS 380 million • And also: How much did online sales increase?

  • Shufersal.

    Broke records

    Photo: 

    Eyal Margolin, Ginny

Shufersal recorded a record revenue in 2020, which generated more than NIS 15.2 billion. 

The company's net profit amounted to NIS 387 million, about 2.5% of revenues, and a profitability index (EBITDA) of about 1.5 billion - which constitutes about 10% of the company's total revenues.

Revenues in the last quarter of 2020 amounted to NIS 4 billion - a jump of about 16% compared to the end of 2019. Net income in the last quarter was NIS 120 million - an increase of 2.6% compared to the corresponding period in 2019.

Shufersal notes that after neutralizing one-time tax revenues in 2019, the annual net profit in 2020 recorded a sharp increase of about 80%, and of 87% in the profit of the last quarter of the year.

Shufersal Online's sales rose dramatically following the corona and amounted to NIS 3 billion in 2020, which constitutes about one-fifth of all food retail sales.

This is a jump of 33% compared to 2019, where sales through the network accounted for only 15% of total sales.

Shufersal's private label continues to strengthen and expand, reaching sales of NIS 3.9 billion this year, which constitutes about 25.8% of the company's total sales.

The BE-cosmetics and pharma chain BE, the competitor of Super-Pharm, which merged into Shufersal at the end of 2019, reached an operating balance for the first time - after reducing the pharma chain's operating loss by more than 70% to NIS 19 million - compared to NIS 70 million in 2019.

The company's revenues increased by 15% and amounted to 815 million in the past year.

Shufersal will distribute a dividend of NIS 140 million, and the company has announced that it will consider issuing shares to institutional investors in the amount of NIS 700 million.

Yaki and Damani, Chairman of the Board of Shufersal, and Itzik Aberkhan, CEO of Shufersal, stated: At the beginning of the year and its impact on the State of Israel at the end of the first quarter, the group was prepared to meet the huge demand for the supply of food products and other basic consumer products, both in physical stores and online. "

Source: israelhayom

All news articles on 2021-03-03

Similar news:

You may like

Trends 24h

News/Politics 2021-04-20T10:02:26.085Z
News/Politics 2021-04-20T07:40:29.902Z
News/Politics 2021-04-20T08:05:35.750Z

Latest

© Communities 2019 - Privacy